Who is the CEO of Molecule Holdings Inc.?

The CEO of Molecule Holdings Inc. is David Reingold.

What industry does Molecule Holdings Inc. belong to?

Molecule Holdings Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.

Where is Molecule Holdings Inc. headquartered?

Molecule Holdings Inc. is headquartered at 591 Reynolds Road, Lansdowne, ON, K0E 1L0, CA.

What is the IPO date of Molecule Holdings Inc.?

Molecule Holdings Inc. went public on September 17, 2020.

How many employees does Molecule Holdings Inc. have?

The total number of employees at Molecule Holdings Inc. is disclosed periodically in the company's annual financial reports.

Molecule Holdings Inc.

MLCL.CN•CNQ

Healthcare

Drug Manufacturers - Specialty & Generic

CA$0.005

CA$0.00(0.00%)

Molecule Holdings Inc. (MLCL.CN) Company Profile & Overview

Explore Molecule Holdings Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Molecule Holdings Inc. (MLCL.CN) Company Profile & Overview

Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages in Canada. It offers its beverage products under the PHRESH, embody, and CANAJO brands. The company is based in Lansdowne, Canada.

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

CEODavid Reingold

Contact Information

https://www.molecule.ca

591 Reynolds Road, Lansdowne, ON, K0E 1L0

Company Facts

IPO DateSep 17, 2020

CountryCA

Frequently Asked Questions

;